OCUL
Ocular Therapeutix·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OCUL fundamentals
Ocular Therapeutix (OCUL) released its earnings on Nov 4, 2025: revenue was 14.54M (YoY -5.74%), missed estimates; EPS was -0.38 (YoY -72.73%), missed estimates.
Revenue / YoY
14.54M
-5.74%
EPS / YoY
-0.38
-72.73%
Report date
Nov 4, 2025
OCUL Earnings Call Summary for Q3,2025
- Wet AMD Milestone: SOL-R trial reaches 555-subject randomization, with SOL-1 on track for Q1 2026 data, targeting a superiority label.
- DR Breakthrough: HELIOS program uses ordinal DRSS endpoint, aiming for a broad label covering NPDR and DME, with single injection lasting 12 months.
- Financial Security: $445M equity financing extends cash runway to 2028, supporting clinical and commercial efforts.
- Strategic Triad: Superiority, market expansion (untreated NPDR patients), and seamless integration into existing workflows drive differentiation.
EPS
Revenue
Revenue & Expenses
OCUL has released its 2025 Q3 earnings report, with revenue of 14.54M, reflecting a YoY change of -5.71%, and net profit of -69.42M, showing a YoY change of -90.22%. The Sankey diagram below clearly presents OCUL's revenue sources and cost distribution.
Key Indicators
Ocular Therapeutix (OCUL) key financial stats and ratios, covering profitability, financial health, and leverage.
Ocular Therapeutix (OCUL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ocular Therapeutix (OCUL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ocular Therapeutix (OCUL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ocular Therapeutix (OCUL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ocular Therapeutix (OCUL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Ocular Therapeutix’s earnings call?Did Ocular Therapeutix beat or miss consensus estimates last quarter?What is the market's earnings forecast for Ocular Therapeutix next quarter?What guidance did Ocular Therapeutix's management provide for the next earnings period?What factors drove the changes in Ocular Therapeutix's revenue and profit?What is the revenue and EPS growth rate for Ocular Therapeutix year over year?What is Ocular Therapeutix's gross profit margin?What were the key takeaways from Ocular Therapeutix's earnings call?
